Reference number : 276-2010-2011-Q2-00184, amendment number : , agreement type : C, recipient legal name : Origin BioMed Inc.|Origin BioMed Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3J 1N7, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 195303, agreement title french : 195303, agreement number : 195303, agreement value : 3000000.0, agreement start date : 2010-08-05, agreement end date : 2013-03-31, description english : The Development of Novel Treatments for Neuropathic Pain, description french : Nouveaux traitements pour douleurs neuropathiques, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement conditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique